Using CancerGRACE.org
Create a Profile
Create a profile on GRACE. Your dashboard lets you save information that is important to you, and allows you to join the conversation! Click the 'My Account' link to return to your dashboard at any time.
Featured Content
The panel discusses the current standard of care for patients with head and neck cancer who need surgery, the findings of the Keynote 689 study, which showed improved EFS in patients with head and neck cancers treated with pembrolizumab, the RTOG 0920 study, and how it may affect their use of cetuximab in clinic, and how surgeons view the various treatment agents for head and neck cancer, and whether they prefer certain ones. To watch the complete playlist click here:
Las biopsias líquidas están revolucionando la forma en que combatimos el cáncer, ofreciendo un futuro donde la detección y el tratamiento son más rápidos, precisos y menos invasivos.
Como parte de la Videoteca de Cáncer de Pulmón en Español 2025, oncólogos expertos discuten las opciones de tratamiento y la información más emergente en cáncer de pulmón. El Dr. Raez aborda la terapia para cánceres de pulmón EGFR y ALK, además de analizar otros tres temas de actualidad. La Dra. Viola y la Dra. Riaño también contribuyen a esta videoteca, cada una presentando tres temas relevantes sobre el cáncer de pulmón. To watch the complete playlist, click here.
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.
In these videos, Dr. Jared Weiss gives a brief overview of NUT Carcinoma, discusses treatment options and possible future treatment. To watch the complete playlist, click here.
Don't let the word "small" deceive you. Small cell lung cancer (SCLC) casts a long shadow, impacting lives with its aggressive nature and the complexities of its treatment. But while the challenges are real, so is the progress. Breakthroughs in small cell lung cancer treatment offer hope. Immunotherapy plus chemo-radiation improves survival by 22 months. Screening catches it early.
In these video series, Dr. Iyengar discusses two indications, or timepoints, where radiation and/or surgery may be used to improve the survival outcomes in metastatic, non-small cell lung cancer (NSCLC) patients, specifically focusing on consolidation. He discusses various trials, but also the importance of how radiation would help patients who were receiving immunotherapy-based regiments. This led to the discussion of NRG-LU002, a randomized phase II/III trial of maintenance systemic therapy vs...